Pr. Florian GUISIER
Fonction : Professeur des Universités - Praticien Hospitalier
Groupe : Quantif
Publications associées
- Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018.
Eur J Cancer · 2023 - RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion.
J Thorac Oncol · 2023 - Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer.
J Immunother Cancer · 2023 - Endoscopic resection of tracheal and bronchial granular cell tumours: A national multicentre retrospective study.
Respirology · 2023 - Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).
Lung Cancer. · 2023 - Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Target Oncol. · 2023 - Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ?50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study).
J Immunother · 2023 - Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1???50% advanced non small cell lung cancer.
J Cancer Res Clin Oncol · 2023 - Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study., Target Oncol, 2023, 18, 585-591. [IF = 5.4].
Target Oncol · 2023 - Assessment of endobronchial ultrasound-guided bronchoscopy (EBUS) intranodal forceps biopsy added to EBUS 19-gauge transbronchial needle aspiration: A blinded pathology panel analysis.
Thorac Cancer · 2023 - Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study.
J Geriatr Oncol, 2023 · 2023 - [Advanced bronchoscopic techniques for the diagnosis of peripheral lung nodule].
Rev Mal Respir · 2023 - Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas.
Cancers (Basel) · 2022 - Endoscopic Follow-up of Low Grade Precancerous Bronchial Lesions in High-Risk Patients: long-term results of the SELEPREBB randomized multicentre trial.
Eur Respir J · 2022 - Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study.
Cancers (Basel) · 2022 - Long-Term Survival Following Minimally Invasive Lung Cancer Surgery: Comparing Robotic-Assisted and Video-Assisted Surgery.
9Cancers (Basel) · 2022 - ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date.
Curr Oncol · 2022 - Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab.
Ann Nucl Med · 2022 - Hypnosis associated with 3D immersive virtual reality technology during bronchoscopy under local anesthesia.
J Thorac Dis · 2022 - Radial-EBUS and virtual bronchoscopy planner for peripheral lung cancer diagnosis: How it became the first-line endoscopic procedure.
Thorac Cancer · 2022 - Management of patients with synchronous head-and-neck and lung cancers: SYNCHRON GFPC 15-01 study.
J Cancer Res Ther · 2022 - Brief Report: First-line Pembrolizumab in Metastatic Non-Small Cell Lung Cancer Habouring MET Exon 14 Skipping Mutation and PD-L1 ≥50% (GFPC 01-20 Study).
Clin Lung Cancer · 2022 - An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology.
Lab Invest · 2021 - Lung cancer surgery after treatment with anti-PD1/PD-L1 immunotherapy for non-small-cell lung cancer: a case-cohort study.
Cancers (Basel) · 2021 - The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives – State of the art.
Cancers (Basel) · 2021 - Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations.
Int J Mol Sci. · 2021 - Virtual Bronchoscopy Planner and Radial-EBUS Guided Biopsy for Organizing Pneumonia Diagnosis.
J Clin Med · 2021 - Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study).
Lung Cancer · 2021 - First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50.
Future Oncol · 2021 - Le RNAseq en oncologie de routine.
Ann Pathol · 2021 - Impact of Programmed Death Ligand 1 expression in advanced non-small–cell lung cancer patients, treated by chemotherapy (GFPC 06-2015 study).
Onco Targets Ther · 2020 - Efficacy of dabrafenib plus trametinib combination in patients with BRAF V600E-mutant NSCLC in real-word setting : GFPC 01-2019.
Cancers (Basel) · 2020 - Circulating tumor DNA as a prognostic determinant in small cell lung cancer patients receiving atezolizumab.
J. Clin. Med · 2020 - Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma.
J Thorac Oncol · 2020 - Efficacy and safety of anti-PD-1 immunotherapy in advanced Non Small Cell Lung Cancer patients with BRAF, HER2 or MET mutation or RET-translocation.
GFPC 01-2018 · 2020 - Immune checkpoint inhibitor re-challenge: outcome analysis in a French national cohort of non-small-cell lung cancer patients.
Clin Lung Cancer · 2020 - Self-expanding metallic Y-stent compared to silicone Y-sent for malignant lesions of the main carina : a signle center retrospective study.
Respir Med Res · 2020 - A simple endoscopic method with radial enbronchial ultrasonography for low-migration rate coil-tailed fiducial marker placement.
J Thorac Dis · 2020 - Crizotiniv(induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient : a case report.
BMC Cancer · 2020 - (2020) Janus or Hydra: the many faces of T helper cells in the human tumour microenvironment.
Adv Exp Med Biol · 2020 - Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma.
Medicine (Baltimore) · 2020 - Management and outcomes of non-small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04)
Cancer Med · 2020 - PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use immunotherapy in these patients: the GFPC 03-2017 « EPNEC » study.
Ther Adv Med Oncol · 2020 - A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer.
Sci Rep · 2019 - In vivo probe-based confocal laser endomicroscopy in chronic interstitial lung diseases : specific descriptors and correlation with chest CT.
Respirology · 2019 - Sub-cutaneous fat mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stageIV non-small cell lung cancer treated by nivolumab.
Oncoimmunology · 2019 - Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Preexisting Autoimmune Disease: A Nationwide Multicenter Cohort Study.
Arthritis Rheumatol · 2019 - Upgrading the repertoire of miRNAs in gastric adenocarcinoma to provide a new resource for biomarker discovery.
Int J Mol Sci · 2019 - Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: a multicentric real-world study (BRIGALK study)
Lung Cancer · 2019 - Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
Lancet Oncol · 2019 - Real-life efficacy of osimertinib in pretreated patients with advanced nonsmall cell lung cancer harboring EGFR T790M mutation.
Lung Cancer · 2019 - A Randomized Non-Comparative Phase 2 Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients with Small Cell Lung Cancer: Results from the IFCT-1603 Trial.
J Thorac Oncol · 2019 - ROS1-rearranged NSCLC With Secondary Resistance Mutation: Case Report and Current Perspectives.
Clin Lung Cancer · 2019 - Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer.
BMC Pulm Med · 2019 - Expanding the Transcriptome of Head and Neck Squamous Cell Carcinoma Through Novel MicroRNA Discovery.
Front. Oncol · 2019